During the past decade, Lei Li conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lei Li" #1 collaborator was "Guangzhou Women and Children's Medical Center" with 2 trials as a collaborator, "Beijing Hospital" with 1 trials as a collaborator, "Beijing Qiyuanjuhe Biotechnology Co., Ltd" with 1 trials as a collaborator, "China-Japan Friendship Hospital" with 1 trials as a collaborator and "Chongqing Medical University No.1 Affiliated Hospital" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Lei Li" are "Epithelial Ovarian Cancer" (11 trials), "DNA Methylation" (8 trials), "Recurrent Cervical Carcinoma" (8 trials), "Survival Outcomes" (7 trials) and "Chemotherapy" (6 trials). Many other conditions were trialed in "Lei Li" in a lesser frequency.

Most popular intervention types in "Lei Li" are "Diagnostic Test" (17 trials), "Drug" (13 trials), "Combination Product" (11 trials), "Procedure" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "DNA methylation testing" (5 trials), "A multi-omics analysis" (3 trials), "TCT" (3 trials), "DNA methylation" (2 trials) and "High-risk HPV" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lei Li" are 57 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "Lei Li". undefined are not yet recruiting, 23 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Lei Li, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lei Li, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".